Renu Goel

Director of Analytical Development and Mass spectrometry at CuriRx, Inc | Boston, Massachusetts, United States

About Renu Goel

Renu Goel serves as the Director of Analytical Development and Mass Spectrometry at CuriRx, Inc. and Northwestern University, where she leads a dynamic team of eight professionals dedicated to advancing pharmaceutical development through innovative analytical methodologies. With over 15 years of experience in both academia and industry, Renu has established herself as a subject matter expert in analytical method development and validation for drug substances (DS) and drug products (DP). Her role encompasses a broad spectrum of responsibilities, including the development and validation of analytical methods for quantifying excipients, conducting routine stability studies, and facilitating method transfers—all critical components in ensuring the efficacy and safety of pharmaceutical dosage forms.

Renu's expertise lies in leveraging advanced techniques such as High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) to drive research in proteomics and metabolomics. Her contributions have been pivotal in the formulation development process, where she applies her deep understanding of biopharmaceuticals and molecular biology to optimize drug formulations. Renu’s proficiency in data analysis and her hands-on experience with Polymerase Chain Reaction (PCR) further enhance her capability to tackle complex analytical challenges.

Key projects under her leadership include the development of robust analytical methods that meet regulatory standards, ensuring the seamless transition of drug candidates from the laboratory to clinical trials. Renu’s commitment to excellence and her ability to foster collaboration within her team have positioned CuriRx at the forefront of pharmaceutical innovation, making significant strides in the biopharmaceutical landscape. Her passion for advancing analytical science not only drives her team's success but also contributes to the broader mission of improving patient outcomes through effective drug development.

Renu Goel Work